🇺🇸 FDA
Patent

US 6251903

Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonist

expired A61KA61K51/0459A61P

Quick answer

US patent 6251903 (Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonist) held by The Regents of the University of California expires Mon Jun 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 26 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K51/0459, A61P, A61P25/00, A61P25/04